Evry, October 10, 2016 – The CEA’s Centre national de Génotypage (French national genome research platform) and the Company Biofacet have announced the start of the second phase of a high speed data processing and sequencing software development (NGS: Next Generation Sequencing). Following the validation of a pilot study carried out in 2015 on exomes, the aim of this second phase is to produce a software platform for storing, organising and querying sequence variants from NGS data on complete genomes ...
Download Press Release (French, English). Paris, June 4, 2019 - Clinical evaluation begins for Diagen™ to take patients’ genomic profiles into account along the nephrology care pathway. In collaboration with the Paris AP-HP public hospital, the project seeks to develop and validate TRAASER’s DiagenTM expert software, associated with large-scale genomic data analysis software by Biofacet, in a kidney disease diagnosis protocol based on DNA sequencing ... Download Press Release (French, English). |